Zusammenfassung
Vitamine, Minerale und Spurenelemente, insbesondere Antioxidanzien, werden von bis zu 70% der onkologischen Patienten in unterschiedlichsten Kombinationen und Konzentrationen eingenommen. Die Rationale für die Einnahme ist unterschiedlich und oft auch unbegründet. Während normal dosierte Mikronährstoffpräparate aufgrund der oft bestehenden Mangelernährung unkritisch sind, ist bei den vielfach empfohlenen hoch dosierten Präparaten, v. a. den Antioxidanzien, die Datenlage unklar und es ist nicht sicher, inwieweit hier statt des positiven Effekts ein negativer eintreten kann. Die Radio- und Chemotherapie wirkt unter anderem über die Bildung reaktiver Sauerstoffverbindungen (ROS), die wiederum durch Antioxidanzien abgefangen werden. ROS sind aber auch für Nebenwirkungen mitverantwortlich, sodass Antioxidanzien hier eher nützlich sein könnten. Dies gilt es bei der Beurteilung der wissenschaftlichen Evidenz für den Einsatz von Antioxidanzien abzuwägen.
Abstract
Vitamins, minerals, trace elements, and especially antioxidants in different combinations and concentrations are taken by 70% of oncological patients. The reasons they consume these micronutrients differ and in many cases are not justified. Multivitamin supplements within a normal range (100% of dietary reference intake) are without any risk for cancer patients; indeed, because these individuals are frequently malnourished, such supplements might be beneficial. However, antioxidants in high concentrations, which are frequently recommended, might be either beneficial or harmful. Radiotherapy and chemotherapy exert some effects on cancer cells via generation of reactive oxygen species (ROS). Antioxidants may neutralise ROS and consequently have a harmful effect regarding therapeutic efficacy. On the other hand, ROS are in part also responsible for side effects of radio- and chemotherapy, so antioxidants might be beneficial. If antioxidants are recommended to cancer patients, these factors must be kept in mind and critically analysed.
Literatur
Anthony HM, Schorah CJ (1982) Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer 46: 354–367
Argyriou AA, Chroni E, Koutras A et al. (2006) A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer 14: 1134–1140
Argyriou AA, Chroni E, Koutras A et al. (2005) Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology 64: 26–31
Assouline S, Miller WH (2006) High-dose vitamin C therapy: renewed hope or false promise? CMAJ 174: 956–957
Besa EC, Abrahm JL, Bartholomew MJ et al. (1990) Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol. Am J Med 89: 739–747
Block KI, Koch AC, Mead MN et al. (2007) Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 33: 407–418
Borek C (2004) Antioxidants and radiation therapy. J Nutr 134: 3207S–3209S
Bryan J, Calvaresi E (2004) Associations between dietary intake of folate and vitamins B-12 and B-6 and self-reported cognitive function and psychological well-being in Australian men and women in midlife. J Nutr Health Aging 8: 226–232
Cameron E, Pauling L (1976) Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.Proc Natl Acad Sci U S A 73: 3685–3689
Chamras H, Barsky SH, Ardashian A et al. (2005) Novel interactions of vitamin E and estrogen in breast cancer. Nutr Cancer 52: 43–48
Daniels JS, Gates KS, Tronche C, Greenberg MM (1998) Direct evidence for bimodal DNA damage induced by tirapazamine. Chem Res Toxicol 11: 1254–1257
Luca C de, Deeva I, Mikhal’Chik E, Korkina L (2007) Beneficial effects of pro-/antioxidant-based nutraceuticals in the skin rejuvenation techniques. Cell Mol Biol (Noisy-le-grand) 53: 94–101
Delanian S, Lefaix JL (2007) Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol 17: 99–107; Review
Delanian S, Porcher R, Rudant J, Lefaix JL (2005) Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 23: 8570–8579
Souza Fede AB de, Bensi CG, Trufelli DC et al. (2007) Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial. Am J Clin Oncol 30: 432–436
Dimery IW, Hong WK, Lee JJ et al. (1997) Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. Ann Oncol 8: 85–89
Diwadkar-Navsariwala V, Diamond AM (2004) The link between selenium and chemoprevention: a case for selenoproteins. J Nutr 134: 2899–2902
Diwadkar-Navsariwala V, Prins GS, Swanson SM et al. (2006) Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A 103: 8179–8184
Drisko JA, Chapman J, Hunter VJ (2003) The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr 22: 118–123
Elango N, Samuel S, Chinnakkannu P (2006) Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation. Clin Chim Acta 373: 92–98; Epub 2006 May 19
Fain O, Mathieu E, Thomas M (1998) Scurvy in patients with cancer. BMJ 316: 1661–1662
Federico A, Iodice P, Federico P et al. (2001) Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutr 55: 293–297
Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G (2005) Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci 9: 361–367
Frank J, Flaccus A, Schwarz C et al. (2006) Ascorbic acid suppresses cell death in rat DS-sarcoma cancer cells induced by 5-aminolevulinic acid-based photodynamic therapy. Free Radic Biol Med 40: 827–836
Frank J, Kelleher DK, Pompella A et al. (1998) Enhancement of oxidative cell injury and antitumor effects of localized 44 degrees C hyperthermia upon combination with respiratory hyperoxia and xanthine oxidase. Cancer Res 58: 2693–2698
Frank J, Lambert C, Biesalski HK et al. (2003) Intensified oxidative and nitrosative stress following combined ALA-based photodynamic therapy and local hyperthermia in rat tumors. Int J Cancer 107: 941–948
Ganser A, Maurer A, Contzen C et al. (1996) Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol. Ann Hematol 72: 237–244
Gatenby RA, Kessler HB, Rosenblum JS et al. (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831–838
Goel S, Agarwal SB, Mandal AK et al. (1999) Emerging role of ascorbic acid in the management of advanced breast carcinoma as a chemosensitizer. Asian J Surg 22: 333–336
Guo G, Yan-Sanders Y, Lyn-Cook BD et al. (2003) Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 23: 2362–2378
Hockel M, Knoop C, Schlenger K et al. (1993) Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26: 45–50
Husbeck B, Peehl DM, Knox SJ (2005) Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing. Free Radic Biol Med 38: 50–57
Israel L, Hajji O, Grefft-Alami A et al. (1985) Vitamin A augmentation of the effects of chemotherapy in metastatic breast cancers after menopause: a randomized trial of 100 patients. Ann Med Interne (Paris) 136: 551–554
Jaakkola K, Lahteenmaki P, Laakso J et al. (1992) Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res 12: 599–606
Jarvinen K, Soini Y, Kahlos K, Kinnula VL (2002) Overexpression of gamma-glutamylcysteine synthetase in human malignant mesothelioma. Hum Pathol 33: 748–755
Jatoi A, Williams B, Nichols F et al. (2005) Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort. Lung Cancer 49: 77–84
Kamphuis MH, Geerlings MI, Grobbee DE, Kromhout D (2007) Dietary intake of B(6–9-12) vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study. Eur J Clin Nutr
Kennedy KA (1987) Hypoxic cells as specific drug targets for chemotherapy. Anticancer Drug Des 2: 181–194
Kinnula K, Linnainmaa K, Raivio KO, Kinnula VL (1998) Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity. Br J Cancer 77: 1097–1102
Kinnula VL, Paakko P, Soini Y (2004) Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett 569: 1–6
Kinnula VL, Lehtonen S, Sormunen R et al. (2002) Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 196: 316–323
Krasner N, Dymock IW (1974) Ascorbic acid deficiency in malignant diseases: a clinical and biochemical study. Br J Cancer 30: 142–145
Kumaraguruparan R, Kabalimoorthy J, Nagini S (2005) Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 38: 154–158
Kumaraguruparan R, Subapriya R, Viswanathan P, Nagini S (2002) Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. Clin Chim Acta 325: 165–170
Kumaraguruparan R, Kabalimoorthy J, Nagini S (2005) Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 38: 154–158
Lehr HA, Germann G, McGregor GP et al. (2006) Consensus meeting on „Relevance of parenteral vitamin C in acute endothelial dependent pathophysiological conditions (EDPC)“. Eur J Med Res 11: 516–526
Leung SW, Mitchell JB, al-Nabulsi I et al. (1993) Effect of L-buthionine sulfoximine on the radiation response of human renal carcinoma cell lines. Cancer 71: 2276–2285
Lesperance ML, Olivotto IA, Forde N et al. (2002) Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat 76: 137–143
Li QQ, Wang WJ, Xu JD et al. (2007) Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells. Cancer Sci 98: 1767–1774
McGregor GP, Biesalski HK (2006) Rationale and impact of vitamin C in clinical nutrition. Curr Opin Clin Nutr Metab Care 9: 697–703
Meyskens FL Jr, Kopecky KJ, Appelbaum FR et al. (1995) Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial. Leuk Res 19: 605–612
Mongan NP, Gudas LJ (2007) Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation
Mook OR, Frederiks WM, Van Noorden CJ (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69–89; Review
Murley JS, Kataoka Y, Cao D et al. (2004) Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat Res 162: 536–546
Myers C, Bonow R, Palmeri S et al. (1983) A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol 10: 53–55
Mystakidou K, Tsilika E, Parpa E et al. (2005) Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Qual Life Res 14: 1825–1833
Neuzil J, Zhao M, Ostermann G et al. (2002) Alpha-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability. Biochem J 362: 709–715
Nordsmark M, Overgaard M, Overgaard J (1996) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31–39
Pace A, Savarese A, Picardo M et al. (2003) Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 21: 927–931
Padayatty SJ, Riordan HD, Hewitt SM et al. (2006) Intravenously administered vitamin C as cancer therapy: three cases. CMAJ 174: 937–942
Pathak A, Bhutani M, Guleria R et al. (2005) Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer. J Am Coll Nutr 24: 16–21
Peralta EA, Viegas ML, Louis S et al. (2006) Effect of vitamin E on tamoxifen-treated breast cancer cells. Surgery 140: 607–614; discussion 614–615
Pinthus JH, Bryskin I, Trachtenberg J et al. (2007) Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. Neoplasia 9: 68–80
Posthauer ME (2006) The role of nutrition in wound care. Adv Skin Wound Care 19: 43–52
Prasad KN (2005) Rationale for using multiple antioxidants in protecting humans against low doses of ionizing radiation. Br J Radiol 78: 485–492
Prasad KN (2004) Rationale for using high-dose multiple dietary antioxidants as an adjunct to radiation therapy and chemotherapy. J Nutr 134: 3182S–3183S
Prasad KN, Cole WC, Kumar B, Che Prasad K (2002) Pros and cons of antioxidant use during radiation therapy. Cancer Treat Rev 28: 79–91
Saintot M, Mathieu-Daude H, Astre C et al. (2002) Oxidant-antioxidant status in relation to survival among breast cancer patients. Int J Cancer 97: 574–579
Sappino AP, Busso N, Belin D, Vassalli JD (1987) Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. Cancer Res 47: 4
Schiff R, Reddy P, Ahotupa M et al. (2000) Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Natl Cancer Inst 92: 1926–1934
Simone CB 2nd, Simone NL, Simone V, Simone CB (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Altern Ther Health Med 13: 40–47
Subapriya R, Kumaraguruparan R, Ramachandran CR, Nagini S (2002) Oxidant-antioxidant status in patients with oral squamous cell carcinomas at different intraoral sites. Clin Biochem 35: 489–493
Takada Y, Hachiya M, Park SH et al. (2002) Role of reactive oxygen species in cells overexpressing manganese superoxide dismutase: mechanism for induction of radioresistance. Mol Cancer Res 1: 137–146
Thews O, Lambert C, Kelleher DK et al. (2007) Impact of therapeutically induced reactive oxygen species and radical scavenging by alpha-tocopherol on tumor cell adhesion. Oncol Rep 18: 965–971
Tipnis SR, Blake DG, Shepherd AG, McLellan LI (1999) Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance. Biochem J 337: 559–566
Ucuncu H, Ertekin MV, Yoruk O et al. (2006) Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced oral mucositis and myelosuppression: a controlled study in a rat model. J Radiat Res (Tokyo) 47: 91–102
Bokhorst-de van der Schuer MA van, Leeuwen PA van, Kuik DJ et al. (1999) The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 86: 519–527
Weijl NI, Elsendoorn TJ, Lentjes EGWM et al. (2004) Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer 40: 1713–1723
Wenzel U, Nickel A, Kuntz S, Daniel H (2004) Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Carcinogenesis 25: 703–712
Yeom CH, Jung GC, Song KJ (2007) Changes of terminal cancer patients‘ health-related quality of life after high dose vitamin C administration. J Korean Med Sci 22: 7–11
Yoon SO, Kim MM, Chung AS (2001) Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem 276: 20085–20092
Interessenkonflikt
Keine Angaben
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Biesalski, HK. Mikronährstoffsupplemente bei onkologischen Patienten. Onkologe 14, 45–57 (2008). https://doi.org/10.1007/s00761-007-1291-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-007-1291-z